140 related articles for article (PubMed ID: 32600105)
1. Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.
van Schaik JE; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; van der Vegt B; Plaat BEC
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1202-1208. PubMed ID: 32600105
[TBL] [Abstract][Full Text] [Related]
2. Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases.
van Schaik JE; van der Vegt B; Slagter-Menkema L; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; Fehrmann RSN; Oosting SF; Plaat BEC
Am J Otolaryngol; 2024 Apr; 45(4):104298. PubMed ID: 38640809
[TBL] [Abstract][Full Text] [Related]
3. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
[TBL] [Abstract][Full Text] [Related]
4. Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.
Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
BMJ Open; 2019 Feb; 9(2):e025359. PubMed ID: 30782931
[TBL] [Abstract][Full Text] [Related]
5. Viable tumor in salvage neck dissections in head and neck cancer: Relation with initial treatment, change of lymph node size and human papillomavirus.
van den Bovenkamp K; Dorgelo B; Noordhuis MG; van der Laan BFAM; van der Vegt B; Bijl HP; Roodenburg JL; van Dijk BAC; Oosting SF; Schuuring EMD; Langendijk JA; Halmos GB; Plaat BEC
Oral Oncol; 2018 Feb; 77():131-136. PubMed ID: 29362119
[TBL] [Abstract][Full Text] [Related]
6. GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.
Kawasaki Y; Suzuki H; Suzuki S; Yamada T; Suzuki M; Ito A; Hatakeyama H; Miura M; Omori Y
Pathol Oncol Res; 2022; 28():1610450. PubMed ID: 36061142
[No Abstract] [Full Text] [Related]
7. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
[TBL] [Abstract][Full Text] [Related]
8. Associations Between [
Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
[TBL] [Abstract][Full Text] [Related]
9. Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate.
Nishio N; van den Berg NS; Martin BA; van Keulen S; Fakurnejad S; Rosenthal EL; Wilson KE
J Nucl Med; 2021 May; 62(5):648-655. PubMed ID: 33008927
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of cervical lymph node metastases in head and neck cancer with ultrasonic measurement of lymph node volume.
Nishio N; Fujimoto Y; Hiramatsu M; Maruo T; Tsuzuki H; Mukoyama N; Yokoi S; Wada A; Kaneko Furukawa M; Furukawa M; Sone M
Auris Nasus Larynx; 2019 Dec; 46(6):889-895. PubMed ID: 30857763
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Ultrasonography-Guided Fine-Needle Aspiration in Detecting Persistent Nodal Disease After Chemoradiotherapy.
Fleischman GM; Thorp BD; Difurio M; Hackman TG
JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):377-82. PubMed ID: 26967355
[TBL] [Abstract][Full Text] [Related]
13. Histogram Analysis Parameters Derived from Conventional T1- and T2-Weighted Images Can Predict Different Histopathological Features Including Expression of Ki67, EGFR, VEGF, HIF-1α, and p53 and Cell Count in Head and Neck Squamous Cell Carcinoma.
Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
Mol Imaging Biol; 2019 Aug; 21(4):740-746. PubMed ID: 30284155
[TBL] [Abstract][Full Text] [Related]
14. ADC-histogram analysis in head and neck squamous cell carcinoma. Associations with different histopathological features including expression of EGFR, VEGF, HIF-1α, Her 2 and p53. A preliminary study.
Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
Magn Reson Imaging; 2018 Dec; 54():214-217. PubMed ID: 30189236
[TBL] [Abstract][Full Text] [Related]
15. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
[TBL] [Abstract][Full Text] [Related]
16. Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.
Fatehi KS; Thiagarajan S; Dhar H; Purandare N; DCruz AK; Chaukar D; Laskar SG; Prabhash K; Rangarajan V
Auris Nasus Larynx; 2019 Aug; 46(4):599-604. PubMed ID: 30594328
[TBL] [Abstract][Full Text] [Related]
17. Associations between Histogram Analysis Parameters Derived from DCE-MRI and Histopathological Features including Expression of EGFR, p16, VEGF, Hif1-alpha, and p53 in HNSCC.
Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
Contrast Media Mol Imaging; 2019; 2019():5081909. PubMed ID: 30718984
[TBL] [Abstract][Full Text] [Related]
18. Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
Hanemaaijer SH; van Gijn SE; Oosting SF; Plaat BEC; Moek KL; Schuuring EM; van der Laan BFAM; Roodenburg JLN; van Vugt MATM; van der Vegt B; Fehrmann RSN
Oral Oncol; 2018 May; 80():33-39. PubMed ID: 29706186
[TBL] [Abstract][Full Text] [Related]
19. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
